Results 201 to 210 of about 567,848 (261)

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

A Data-Centric Approach for Health Care and Research in a Health Knowledge Management Platform: Implementation and Requirement-Based Evaluation Study. [PDF]

JMIR Med Inform
Schreiweis B, Kinast B, Ulrich H, Bronsch T, Kock-Schoppenhauer AK, Bergh B.   +5 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Assessment of multidimensional functional recovery post-stroke: a systematic review of outcome measures and their psychometric properties. [PDF]

BMC Neurol
Pise O, Kamble S, Ghorpade A.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Heuristic multi-site optimization for protein sequence design using Masked Protein Language Models. [PDF]

PLoS Comput Biol
Wang L, Wang Y, Qiu C, Xiao L, Liu X, Chen J.   +5 more
europepmc   +1 more source

Challenges and opportunities in designing innovative emergency-evacuation equipment for bed-dependent hospital patients: a scoping review with a focus on evacuation mattresses and stretchers. [PDF]

BMC Emerg Med
Fattahipour R, Teymouri F, Sharififar S, Khankeh HR, Azizi M.   +4 more
europepmc   +1 more source

Artificial intelligence in orthopedic regenerative medicine: from design to clinical translational pathways. [PDF]

Front Cell Dev Biol
Xu T, Chen W, Chai Y, Hong J, Wu Y, Xu Y, Qiu S, Luo Q.   +7 more
europepmc   +1 more source

Human Islet. [PDF]

Cell Prolif
Zou J, Li S, Fu H, Zhang M, Hu A, Tian X, Du Y, Wei L, Chen X, Gao J, Liang R, Feng X, Li Y, Wang Y, Cai X, Sun P, Ding X, Zhang B, Liu T, Liu N, Hao J, Wang L, Zhao H, Cao J, Ma A, Zhu L, Li Q, Wei Q, Ding X, Cheng Y, Zhao T, Wang S.   +31 more
europepmc   +1 more source

Prosthetic maintenance profiles and functional performance of single-implant mandibular overdentures in geriatric edentulism: A prospective clinical evaluation. [PDF]

Bioinformation
Kaur D, Kaur R, Garg M, Mansuri S, Patel R, K V R, Tiwari R, M C P.   +7 more
europepmc   +1 more source